Eleanor was sitting at her friend Margaret’s house when she noticed a dog sniffing around the couch. She asked Margaret when she got the dog. Margaret said she didn’t have a dog. Eleanor realized she must be experiencing what her doctor warned her about when he increased her Parkinson’s disease (PD) medication dosage: hallucinations. She called her doctor that afternoon.
Before Miguel was diagnosed with Parkinson’s disease (PD) he often experienced anxiety. He retired early, but his anxiety would keep coming back, aggravating his tremor and making his thoughts race. His doctor started him on an antidepressant and referred him to a psychiatrist who taught Miguel coping skills, allowing him to better manage his anxiety. Miguel now lives a more normal life.
Mucuna pruriens variant utilis (MP) has long been used as an alternative to over the counter levodopa. MP is a leguminous plant that grows in both tropical and subtropical environments. Hidden in its seed is levodopa, which is the most important medication for a Parkinson’s disease patient. In this month’s What’s Hot we will review the studies supporting MP use and discuss future directions and global implications for this therapy.
The only people who genuinely understand the complexity of being a caregiver to someone with Parkinson’s disease (PD) are people who are or have been caregivers themselves. That’s why we partnered with Honor to gather helpful tips from the people who know best: experienced caregivers. After hearing from 120 Parkinson’s caregivers, we compiled the top seven tips every Parkinson’s caregiver should know in order to prepare for the journey ahead:
Living with Parkinson’s can be stressful, triggering a cascade of worries. Anxiety is common among people with Parkinson’s and can take many forms: general anxiety, panic attacks, social phobia or attacks brought on by isolated instances, to name a few.
There are approximately 3,000 movement disorder specialists in the world. While they are all neurologists, not all of them have experience treating Parkinson’s disease (PD). For every person with Parkinson’s to receive treatment from a specialist, each one of these doctors would have to treat more than 3,000 people with PD. Parkinson’s Foundation estimates that the average movement disorder specialist sees a total of 350 patients. That’s more than 8.9 million people with PD who are not being treated by a specialist.
Should we consider subcutaneous apomorphine infusions for Parkinson’s disease patients who do not want deep brain stimulation or a dopamine pump? There is a growing interest among people with Parkinson’s disease (PD) and families for a “nonsurgical” alternative to deep brain stimulation (DBS) surgery or to Duopa pump therapy. The idea of brain surgery or a feeding tube have been cited as being undesirable for large numbers of PD patients.
Parkinson’s disease (PD) has seen an elevation in recognition over the last few decades. Through the help of media, celebrities and events that promote PD awareness, Parkinson’s is far from an unknown disease. While we still have a long way to go to educate and make everyone aware of Parkinson’s and its impact, the history of this disease goes back to 1,000 B.C.
With medical marijuana legalized in 28 states and Washington, D.C., its therapeutic properties have become buzzworthy. Researchers are currently studying these properties and how they affect different diseases, like Parkinson’s disease (PD). But why?
Part of Steven Goldenthal’s job is to get people connected. He wants to know how they feel, gets to know their medical history, what medications they take and if they are happy with their Parkinson’s disease (PD) care.